stockrowTwist Bioscience Corporation
TWST Healthcare Biotechnology
Twist Bioscience Corporation’s revenue for fiscal 2025 (year ended September 2025) was $376.6 million, up 20.3% from fiscal 2024.
- Revenue
- +23.2%
- EPS
- −264.7%
- Free cash flow
- −7.23%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
Follow TWST
Alert me
Twist Bioscience Corporation (TWST) Gross margin
Twist Bioscience Corporation's gross margin over the twelve months to 30 June 2026 was 52.0%, up 1.3 percentage points from fiscal 2025 (50.7%). Over the past ten years it has ranged from −315.2% (fiscal 2016) to 50.7% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 65.2% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 50.7% | 8.11 |
| FY2024 | 42.6% | 6.00 |
| FY2023 | 36.6% | (4.77) |
| FY2022 | 41.4% | 2.30 |
| FY2021 | 39.1% | 7.23 |
| FY2020 | 31.9% | 19.05 |
| FY2019 | 12.8% | 39.39 |
| FY2018 | −26.6% | 96.50 |
| FY2017 | −123.1% | 192.11 |
| FY2016 | −315.2% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 52.8% | 1.17 |
| Mar 2026 | 51.6% | (0.46) |
| Dec 2025 | 52.1% | 0.70 |
| Sep 2025 | 51.4% | (2.05) |
| 31 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| PTGX Protagonist Therapeutics, Inc. compare | 100.0% |
| SYRE Spyre Therapeutics, Inc. compare | 100.0% |
| IBRX ImmunityBio, Inc. compare | 99.3% |
| KRYS Krystal Biotech, Inc. compare | 94.3% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | 91.0% |
| TGTX TG Therapeutics, Inc. compare | 82.4% |
| TWST Twist Bioscience Corporation | 52.0% |
| CYTK Cytokinetics, Incorporated compare | 0.00% |
| CAI Caris Life Sciences,�Inc. compare | 0.00% |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TWST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement